1979
DOI: 10.1210/endo-104-6-1805
|View full text |Cite
|
Sign up to set email alerts
|

In UteroRegulation of Rhesus Monkey Fetal Adrenals: Effects of Dexamethasone, Adrenocorticotropin, Thyrotropin-Releasing Hormone, Prolactin, Human Chorionic Gonadotropin, and α-Melanocyte-Stimulating Hormone on Fetal and Maternal Plasma Steroids*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
19
0

Year Published

1981
1981
2007
2007

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 85 publications
(21 citation statements)
references
References 32 publications
2
19
0
Order By: Relevance
“…DEX treatment elicited an acute reduction in maternal plasma cortisol titers, directly in line with what has been reported several times in rhesus macaques (20,21,47,48) and reflecting treatment efficacy in terms of HPA-negative feedback (4), albeit in the circulation of the pregnant female rather than the fetuses. There was no effect of either EDEX or LDEX on the weight of the female, which included the fetoplacental unit; in the rhesus macaque, there is no effect of GCs on fetal body weight after cesarean delivery (20,21,24).…”
Section: Discussionsupporting
confidence: 83%
“…DEX treatment elicited an acute reduction in maternal plasma cortisol titers, directly in line with what has been reported several times in rhesus macaques (20,21,47,48) and reflecting treatment efficacy in terms of HPA-negative feedback (4), albeit in the circulation of the pregnant female rather than the fetuses. There was no effect of either EDEX or LDEX on the weight of the female, which included the fetoplacental unit; in the rhesus macaque, there is no effect of GCs on fetal body weight after cesarean delivery (20,21,24).…”
Section: Discussionsupporting
confidence: 83%
“…It is generally believed that Dex and betamethasone cross the placenta more readily than the natural glucocorticoid ligands because they are not bound to transporter proteins in maternal blood, nor are they as easily converted to cortisone by placental enzymes like 11 beta-hydroxysteroid dehydrogenase (11b-HSD). Once in the fetal compartment, the drugs affect hormone secretion and the unique fetal zone of the adrenal, resulting in a reduction of cortisol, dehydroepiandrosterone (DHEA) and possibly other adrenal androgens [16,17]. Because DHEA is an important precursor of the estrogen produced by the placenta, its inhibition may also explain the decline in maternal estrogen levels during Dex treatment [18].…”
Section: Fetal/placenta/uterine Physiologymentioning
confidence: 99%
“…In the monkey, cortisol of maternal origin accounts for much of the hormone present in the fetal compartment through mid-gestation (7). At high levels, especially if administered to the mother at pharmacological doses, it exceeds the capacity of the fetus to convert the hormone to less active forms, such as cortisone, or to shunt it back across the placenta (8). Then there can be deleterious effects on organ development, especially for hormonesensitive glands like the thymus (9).…”
mentioning
confidence: 99%